Despite these varied results, a recurring theme in the sources is that even if an increased risk exists, its absolute magnitude is low, and the well-documented benefits of GLP-1 RAs for managing diabetes and cardiovascular health likely outweigh this potential concern for most patients [7,10-12]. This evidence concerns the gene GCG and diabetes mellitus.